During the past decade, ThedaCare Regional Cancer Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 30 clinical trials were completed, i.e. on average, 44.1% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 14 clinical trials were completed. i.e. 32.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ThedaCare Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "Radiation Therapy Oncology Group" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ThedaCare Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator and "Canadian Cancer Trials Group" with 5 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "ThedaCare Regional Cancer Center" are "Breast Cancer" (8 trials), "Prostate Cancer" (7 trials), "Invasive Breast Carcinoma" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials) and "Head and Neck Cancer" (4 trials). Many other conditions were trialed in "ThedaCare Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "ThedaCare Regional Cancer Center" are "Drug" (69 trials), "Other" (61 trials), "Biological" (40 trials), "Radiation" (36 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (34 trials), "Questionnaire Administration" (22 trials), "Biospecimen Collection" (19 trials), "Computed Tomography" (19 trials) and "Laboratory Biomarker Analysis" (17 trials). Other intervention names were less common.

The vast majority of trials in "ThedaCare Regional Cancer Center" are 77 trials for "All" genders, 14 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "ThedaCare Regional Cancer Center". undefined are not yet recruiting, 37 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in ThedaCare Regional Cancer Center, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ThedaCare Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".